JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR/ LU2314628996 /
| NAV6/10/2024 | Chg.-0.0100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 65.9400EUR | -0.02% | reinvestment | Equity | JPMorgan AM (EU) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 6/12/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 3/1/2024 | Prospectus | 2024 | English | 12,571.47 KB |
| 3/1/2024 | Prospectus | 2024 | German | 13,030.79 KB |
| 12/31/2023 | Semi-annual report | 2023 | English | 2,988.31 KB |
| 12/31/2023 | Semi-annual report | 2023 | German | 3,041.32 KB |
| 12/6/2023 | PRIIP Key Information Document | 2023 | English | 96.83 KB |
| 12/6/2023 | PRIIP Key Information Document | 2023 | German | 101.65 KB |
| 6/30/2023 | Account statment | 2023 | English | 15,502.94 KB |
| 6/30/2023 | Account statment | 2023 | German | 13,816.29 KB |
| 11/8/2022 | Key Investor Information | 2022 | English | 79.05 KB |
| 11/8/2022 | Key Investor Information | 2022 | German | 81.44 KB |
